LATRICE MALLARD: Open Payments
NPI 1225565807 · KENTWOOD, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$221 in 11 payments from 7 companies in 2025. Trend: 2023 $96 · 2024 $452 · 2025 $221
Food & beverage: $221
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $60 |
| Alkermes, Inc. | 2 | $41 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| Vanda Pharmaceuticals Inc. | 1 | $33 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
| Medtronic, Inc. | 1 | $16 |
| Collegium Pharmaceutical, Inc. | 1 | $15 |
Products named: CAPLYTA, ABILIFY ASIMTUFII, FANAPT, VIVITROL, COBENFY, VENASEAL, ARISTADA, Jornay PM.
Industry payments across LA — which companies pay providers there.
